BLAIR WILLIAM & CO/IL

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$446K	86K	-204,517	-70.4%	$5.19	Q3 2024
6/30/2024	0%	0%	$747K	291K	-38,752	-11.8%	$2.57	Q2 2024
3/31/2024	0.01%	+0%	$1.62M	329K	+36,318	+12.4%	$4.92	Q1 2024
12/31/2023	0.01%	0%	$2.58M	293K	-33,357	-10.2%	$8.79	Q4 2023
9/30/2023	0.01%	-0.01%	$3.74M	326K	-169,969	-34.2%	$11.47	Q3 2023
6/30/2023	0.05%	+0.02%	$12.6M	496K	+189,398	+61.7%	$25.31	Q2 2023
3/31/2023	0.04%	+0.02%	$9.88M	307K	+181,372	+145%	$32.21	Q1 2023
12/31/2022	0.01%	+0%	$2.32M	126K	+15,200	+13.8%	$18.46	Q4 2022
9/30/2022	0.01%	+0.01%	$2.98M	110K	+96,112	+677%	$27.00	Q3 2022
6/30/2022	0%	+0%	$196K	14.2K	+1,542	+12.2%	$13.81	Q2 2022
3/31/2022	0%	0%	$247K	12.7K	-300	-2.32%	$19.52	Q1 2022
12/31/2021	0%	0%	$211K	13K	-93,280	-87.8%	$16.29	Q4 2021
9/30/2021	0.01%	+0%	$2.96M	106K	+35,597	+50.4%	$27.86	Q3 2021
6/30/2021	0.01%	+0%	$2.09M	70.6K	+29,120	+70.1%	$29.65	Q2 2021
3/31/2021	0%	+0%	$1.16M	41.5K	+21,033	+103%	$27.94	Q1 2021
12/31/2020	0%	+0%	$580K	20.5K	+9,640	+88.9%	$28.32	Q4 2020
9/30/2020	0%	0%	$273K	10.8K	-11,895	-52.3%	$25.18	Q3 2020
6/30/2020	0%	+0%	$555K	22.7K	+4,036	+21.6%	$24.41	Q2 2020
3/31/2020	0%	+0%	$277K	18.7K	+3,250	+21%	$14.81	Q1 2020
12/31/2019	0%	+0%	$251K	15.5K	+15,450	NEW	$16.25	Q4 2019
6/30/2018		0%	$0	0	-8,250	-100%		Q2 2018
3/31/2018	0%	0%	$254K	8.25K	-4,700	-36.3%	$30.79	Q1 2018
12/31/2017	0%	+0%	$463K	13K	+12,950	NEW	$35.75	Q4 2017
12/31/2015		-0.01%	$0	0	-22,007	-100%		Q4 2015
9/30/2015	0.01%	+0.01%	$654K	22K	+22,007	NEW	$29.72	Q3 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.